Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1983 Apr;47(4):527–536. doi: 10.1038/bjc.1983.83

Concanavalin A acceptor glycoproteins: a new type of marker for the classification of tumour cells.

G L Koch, M J Smith
PMCID: PMC2011341  PMID: 6849797

Abstract

The Con A acceptor glycoproteins of murine and human tumour cell lines revealed by two-dimensional fingerprinting on polyacrylamide gels fall into two main categories: constant glycoproteins expressed by all cell lines and variable glycoproteins which are only expressed by particular tumour cell lines. Since the number of variable glycoproteins on a typical fingerprint is 50, fingerprints from different cell lines are readily distinguishable. However the variable glycoproteins are not expressed idiosyncratically and cell lines derived from similar classes of tumours express similar patterns of the variable glycoproteins. For example, murine fibrosarcomas express patterns which are virtually identical with one another. Characteristic patterns are also expressed by murine macrophage tumour lines, human carcinomas and human B lymphoblastoid cells. Thus, the variable glycoproteins behave as a set of linked markers which are indicators of the type of normal pre-neoplastic precursor cell from which a tumour is derived and appear to be a new type of marker for tumour cell classification. Antibodies to these glycoproteins could prove useful in tumour localisation and diagnosis.

Full text

PDF
527

Images in this article

529Figure 1
on p.529
530Figure 2
on p.530
530Figure 3
on p.530
531Figure 4
on p.531
532Figure 5
on p.532
532Figure 6
on p.532

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkinson M. A., Bramwell M. E. Studies on the surface properties of hybrid cells. III. A membrane glycoprotein found on the surface of a wide range of malignant cells. J Cell Sci. 1981 Apr;48:147–170. doi: 10.1242/jcs.48.1.147. [DOI] [PubMed] [Google Scholar]
  2. Basombrío M. A. Search for common antigenicities among twenty-five sarcomas induced by methylcholanthrene. Cancer Res. 1970 Oct;30(10):2458–2462. [PubMed] [Google Scholar]
  3. Bramwell M. E., Harris H. An abnormal membrane glycoprotein associated with malignancy in a wide range of different tumours. Proc R Soc Lond B Biol Sci. 1978 Apr 13;201(1142):87–106. doi: 10.1098/rspb.1978.0034. [DOI] [PubMed] [Google Scholar]
  4. DUNN T. B., POTTER M. A transplantable mast-cell neoplasm in the mouse. J Natl Cancer Inst. 1957 Apr;18(4):587–601. [PubMed] [Google Scholar]
  5. Der C. J., Stanbridge E. J. A tumor-specific membrane phosphoprotein marker in human cell hybrids. Cell. 1981 Nov;26(3 Pt 1):429–438. doi: 10.1016/0092-8674(81)90212-9. [DOI] [PubMed] [Google Scholar]
  6. Fogh J., Fogh J. M., Orfeo T. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst. 1977 Jul;59(1):221–226. doi: 10.1093/jnci/59.1.221. [DOI] [PubMed] [Google Scholar]
  7. Gartler S. M. Apparent Hela cell contamination of human heteroploid cell lines. Nature. 1968 Feb 24;217(5130):750–751. doi: 10.1038/217750a0. [DOI] [PubMed] [Google Scholar]
  8. Glynn J. P., McCoy J. L., Fefer A. Cross-resistance to the transplantation of syngeneic Friend, Moloney, and Rauscher virus-induced tumors. Cancer Res. 1968 Mar;28(3):434–439. [PubMed] [Google Scholar]
  9. Grant A. G., Duke D., Hermon-Taylor J. Establishment and characterization of primary human pancreatic carcinoma in continuous cell culture and in nude mice. Br J Cancer. 1979 Feb;39(2):143–151. doi: 10.1038/bjc.1979.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Greaves M. F. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia. Cancer Res. 1981 Nov;41(11 Pt 2):4752–4766. [PubMed] [Google Scholar]
  11. Hood L., Huang H. V., Dreyer W. J. The area-code hypothesis: the immune system provides clues to understanding the genetic and molecular basis of cell recognition during development. J Supramol Struct. 1977;7(3-4):531–559. doi: 10.1002/jss.400070321. [DOI] [PubMed] [Google Scholar]
  12. Horibata K., Harris A. W. Mouse myelomas and lymphomas in culture. Exp Cell Res. 1970 Apr;60(1):61–77. doi: 10.1016/0014-4827(70)90489-1. [DOI] [PubMed] [Google Scholar]
  13. Koren H. S., Handwerger B. S., Wunderlich J. R. Identification of macrophage-like characteristics in a cultured murine tumor line. J Immunol. 1975 Feb;114(2 Pt 2):894–897. [PubMed] [Google Scholar]
  14. Lampson L. A., Levy R. A role for clonal antigens in cancer diagnosis and therapy. J Natl Cancer Inst. 1979 Feb;62(2):217–220. [PubMed] [Google Scholar]
  15. Metcalf D. Clonal analysis of the action of GM-CSF on the proliferation and differentiation of myelomonocytic leukemic cells. Int J Cancer. 1979 Nov 15;24(5):616–623. doi: 10.1002/ijc.2910240515. [DOI] [PubMed] [Google Scholar]
  16. Mintz B., Fleischman R. A. Teratocarcinomas and other neoplasms as developmental defects in gene expression. Adv Cancer Res. 1981;34:211–278. doi: 10.1016/s0065-230x(08)60243-2. [DOI] [PubMed] [Google Scholar]
  17. O'Farrell P. H. High resolution two-dimensional electrophoresis of proteins. J Biol Chem. 1975 May 25;250(10):4007–4021. [PMC free article] [PubMed] [Google Scholar]
  18. O'Toole C. M., Tiptaft R. C., Stevens A. HLA antigen expression on urothelial cells: detection by antibody-dependent cell-mediated cytotoxicity. Int J Cancer. 1982 Apr 15;29(4):391–395. doi: 10.1002/ijc.2910290405. [DOI] [PubMed] [Google Scholar]
  19. Potter V. R. Phenotypic diversity in experimental hepatomas: the concept of partially blocked ontogeny. The 10th Walter Hubert Lecture. Br J Cancer. 1978 Jul;38(1):1–23. doi: 10.1038/bjc.1978.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Povey S., Hopkinson D. A., Harris H., Franks L. M. Characterisation of human cell lines and differentiation from HeLa by enzyme typing. Nature. 1976 Nov 4;264(5581):60–63. doi: 10.1038/264060b0. [DOI] [PubMed] [Google Scholar]
  21. Sikora K., Koch G., Brenner S., Lennox E. Partial purification of tumour-specific transplantation antigens from methylcholanthrene-induced murine sarcomas by immobilized lectins. Br J Cancer. 1979 Dec;40(6):831–838. doi: 10.1038/bjc.1979.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Springer T., Galfré G., Secher D. S., Milstein C. Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur J Immunol. 1979 Apr;9(4):301–306. doi: 10.1002/eji.1830090410. [DOI] [PubMed] [Google Scholar]
  23. Stevenson G. T., Elliott E. V., Stevenson F. K. Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: a therapeutic target. Fed Proc. 1977 Aug;36(9):2268–2271. [PubMed] [Google Scholar]
  24. Ware L. M., Axelrad A. A. Inherited resistance to N- and B-tropic murine leukemia viruses in vitro: evidence that congenic mouse strains SIM and SIM.R differ at the Fv-1 locus. Virology. 1972 Nov;50(2):339–348. doi: 10.1016/0042-6822(72)90385-6. [DOI] [PubMed] [Google Scholar]
  25. Warner N. L., Moore M. A., Metcalf D. A transplantable myelomonocytic leukemia in BALB-c mice: cytology, karyotype, and muramidase content. J Natl Cancer Inst. 1969 Oct;43(4):963–982. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES